Tuesday 16 February 2016
Royal Society of Medicine
1 Wimpole Street
**This event has now passed, 2017 date to be announced**
Disease risks at the individual and population level originate from the dynamic interplay of human genes, microbial genes, diet, lifestyle and environments. The changing nature of these interactions constantly challenges us with emergent and shifting patterns of disease happening regularly.
To understand current disease profiles and how to optimally diagnose, treat and prevent them is dependent on understanding of the cause and development of a disease and the biological variations in patients with diseases. New technologies and integrative systems can help us understand the complexity of human diseases, but our technological firepower is increasingly confounded by changes in disease biology and prevalence – whether it be due to poor lifestyle choices or the ineffective translation and deployment of new scientific tools and models.
In this lecture, Professor Jeremy Nicholson, Head of the Department of Surgery and Cancer at Imperial College London, will be juxtaposing some of major challenges in personalised medicine and public health. He will look at how developing new clinically actionable technologies can both help guide new choices in personalised acute medicine and surgery and inform future healthcare policy in the changing face of human disease.
About Professor Jeremy Nicholson:
Professor Jeremy Nicholson obtained his PhD in biochemistry from St Thomas’s Hospital Medical School, London University. After several London university academic appointments in pharmacology he became Head of Biological Chemistry at Imperial College London in 1998, and then Head of the Department of Surgery and Cancer. He is also the Director of the MRC-NIHR National Phenome Centre and runs the cross disciplinary stratified medicine theme of the Imperial NIHR Biomedical Research Centre.
He is a founder director of Metabometrix, who specialise in molecular phenotyping, toxicological screening and clinical diagnostics. Professor Nicholson is a Fellow of the Academy of Medical Sciences and has received numerous awards and international prizes for his work in Systems Medicine and is a Thompson Reuters Highly cited scientist in Pharmacology and Toxicology. One of his major research focus is on microbiome-host metabolic signalling and the role of the microbiome in personalised healthcare and disease risks for diabetes, autism and cancer.
Mr B Sethia, President, Royal Society of Medicine
The London Clinic lecture: Developing new systems medicine technologies and approaches to meet healthcare challenges in a changing world
Professor Jeremy Nicholson, Imperial College London
Vote of thanks
Professor Robin Williamson, Chairman of the Trustees, The London Clinic
Open to all attendees
For those who have pre-booked